SEVIS

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Australia budget update faces fresh pressure as inflation hits 4.3%

Evolution Mining’s Carnaby acquisition nears completion as A$22m Glencore share settlement advances

UK immigration overhaul: Shabana Mahmood prepares 10-year settlement rule

Neuren Pharmaceuticals (ASX: NEU) gains fourth US orphan drug designation for NNZ-2591

Representative image: Indian students reviewing university admission papers, passports and visa timelines as the Fall 2026 U.S. study abroad cycle becomes more competitive for applicants facing tighter embassy appointment windows and stricter interview scrutiny.

Indian students chasing US Fall 2026 admits face their most competitive visa cycle yet, warns Prodigy Finance

Prodigy Finance says May has become the make-or-break month for Indian students chasing US Fall 2026 admits as visa timelines and embassy pressure tighten.

byVenkatesh

May 21, 2026

Representative image: international students taking legal action

SEVIS nightmare: International students blindsided by visa cancellations

International students sue Trump administration over abrupt SEVIS terminations, citing unlawful visa revocations and due process violations.

byPallavi Madhiraju

April 16, 2025

The Latest

Australia budget update faces fresh pressure as inflation hits 4.3%

Evolution Mining’s Carnaby acquisition nears completion as A$22m Glencore share settlement advances

UK immigration overhaul: Shabana Mahmood prepares 10-year settlement rule

Neuren Pharmaceuticals (ASX: NEU) gains fourth US orphan drug designation for NNZ-2591

Indian students chasing US Fall 2026 admits face their most competitive visa cycle yet, warns Prodigy Finance

SEVIS nightmare: International students blindsided by visa cancellations

Australia budget update faces fresh pressure as inflation hits 4.3%

Evolution Mining’s Carnaby acquisition nears completion as A$22m Glencore share settlement advances

UK immigration overhaul: Shabana Mahmood prepares 10-year settlement rule

Neuren Pharmaceuticals (ASX: NEU) gains fourth US orphan drug designation for NNZ-2591

Coursera (NYSE: COUR) plunges 26% as Udemy savings accelerate. Where is the growth?

Trump administration loses Alaska Senate ballot case as judge rejects election delay

Whitehaven Coal’s A$1bn Winchester South project clears major court hurdle but approvals remain outstanding

Sun Pharmaceutical (SUNPHARMA) gains US approval for ILUMYA as Q2 profit falls 36%